Clinical trial
A Phase 1 Mass Balance Study of TS-172 in Healthy Adult Subjects
NCT06596356 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Mass Balance Study of TS-172 in Healthy Adult Subjects
- Lead sponsor
- Taisho Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 26, 2024
- Completion date
- October 28, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy male subjects